archive
· today in ai · 2026-07-15
OpenAI researcher in talks for $2B startup
Archive item — written before sources were shown.
Miles Wang is reportedly raising around $200M at a $2B valuation for an AI drug-repurposing startup, with Lightspeed said to be in talks to lead.
Wang, who joined OpenAI in 2024 after leaving Harvard, is departing to build a startup applying AI to find new uses for existing or previously failed drugs; several other OpenAI researchers may join him. Wang disputed the reported figures without offering corrected ones.
sources
- 01OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2Btechcrunch.com · reporting
Rami Steitieh